Pitching events, Online

TechInvest HealthTech Showcase

The next Mayor of London’s TechInvest, taking place 27th April, will celebrate 10 of London’s pioneering Healthtech startups. This upcoming TechInvest instalment will seek to identify industry leaders that are converging technologies with medicine and healthcare to improve the efficiency and delivery of prediction, prevention, diagnosis, treatment and care.

Connect with HealthTech pioneers, delivering innovative solutions to revolutionise the healthcare industry – this is an opportunity to engage with a group of exciting, industry defining start-ups and scaleups from across the sector, enabling them to accelerate their growth.


Dr Pooja Sikka, Partner, Octopus Ventures

A practising GP by background, Pooja has over 16 years experience working across the healthcare sector with public and private bodies and NHS providers, leading multiple teams through high profile national and international projects and ventures. Pooja’s diverse clinical, managerial and entrepreneurial background has put her at the forefront of the changing healthcare landscape in Europe and emerging economies. She is known in the NHS for her health tech expertise and most recently set up a national programme for the NAPC (National Association of Primary Care), to help NHS providers select and roll out health tech products and services. She serves as a council member and clinical advisor to NAPC and, as a founding member of the EY Ventures team, ran the health and social care investment portfolio.

Dr Benedict Evans, Managing Director, InHealth Ventures

Ben leads InHealth Ventures, an early stage, transatlantic, venture capital fund that invests across digital health and medtech. He started his career as a physician, practising in the NHS for five years before transitioning to McKinsey and Company’s healthcare practice, working in London, Boston and New York. We was subsequently Associate Director of Transformation at St. George’s Hospital NHS Foundation Trust in south London. Ben studied medicine at University College Medical School, London and is a member of the Royal College of Surgeons of England.

Amelia Armour, Partner, Amadeus Capital

Amelia joined Amadeus Capital Partners in 2009 and is a Partner in the Early Stage Fund. Her current investment focus is on autonomous systems, AI and machine learning, cloud computing, digital health, and medical technology.

She is a Director on several boards including Xampla, who have developed a plant-based material to replace single-use plastics; Paragraf who are manufacturing graphene-based electronic devices; Immense Simulations intelligent mobility enabling software company; Riverlane a developer of an operating system for quantum computers and SLAMcore, a spin-out from Imperial College, developing spatial intelligence for autonomous robotics and drones.

Amelia is also an active board observer at other companies including enterprise voice assistant company PolyAI and Graphcore, the developer of the Intelligence Processing Unit for next generation machine intelligence.

Prashant Shah, Executive Chairman, o2h group

Prashant is the co-founder of o2h group which seeds life science and technology businesses and is also a General Partner of the o2h EIS Therapeutics and AI fund. He has previously co-founded two companies in the life science and technology sectors and began his career with the strategy group of Accenture in London where he worked across various industry groups. Prashant has a BEng, MSc and an MPhil in Management from the University of Cambridge.

Neelam Patel, Chief Executive Officer, MedCity

Neelam is CEO of MedCity, the life sciences cluster organisation for London, which plays a pivotal role in bridging industry, NHS and academia. Neelam’s extensive experience spans the private, public and not-for-profit sectors. She has worked with the Association of British Pharmaceutical Industries, the European Innovative Medicines Initiative and collaborated with NHS England, NICE and Public Health England.

Neelam regularly supports companies with R&D, advising on the UK regulatory and access landscape. Other roles include the NICE digital health technology evaluation steering group, the advisory group for PHE digital health evaluation, the advisory board of the Pan-London NIHR Research Design Service and the board of the Health Research Authority.

Tags: TechInvest ,
Date and time
27 April 2021
10:30 - 12:00
Venue Address

This is an online webinar and Q&A held on Zoom. Please register below to secure your place.


Book now